Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.6%

1 terminated out of 38 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

16%

6 trials in Phase 3/4

Results Transparency

33%

4 of 12 completed with results

Key Signals

4 with results92% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (3)
P 1 (6)
P 2 (2)
P 3 (1)
P 4 (5)

Trial Status

Unknown13
Completed12
Recruiting5
Not Yet Recruiting4
Active Not Recruiting2
Enrolling By Invitation1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT05325008Phase 3Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

NCT07204080Phase 2Not Yet Recruiting

(TNX-1500) in Kidney Transplant Recipients

NCT07083830Phase 1Not Yet RecruitingPrimary

ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants

NCT05525507Phase 1Recruiting

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

NCT05806749Phase 1Active Not Recruiting

Immunological Tolerance in Patients With Mismatched Kidney Transplants

NCT07145944Not Yet RecruitingPrimary

To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation

NCT03380962Phase 1Active Not Recruiting

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

NCT05285878Phase 2Enrolling By Invitation

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

NCT03611621CompletedPrimary

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

NCT06016283CompletedPrimary

Sex Impact on Long-term Outcomes of LDKT

NCT04057742CompletedPrimary

AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation

NCT05816486CompletedPrimary

BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

NCT03511560Phase 4Completed

Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation

NCT03955172Not ApplicableRecruitingPrimary

Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection

NCT06394596CompletedPrimary

Predicting Prognostic Factors in Kidney Transplantation Using A Machine Learning

NCT04369612Not ApplicableRecruitingPrimary

Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples

NCT04019353CompletedPrimary

Cf-DNA Assay During Treatment of Acute Rejection

NCT04388930Unknown

The Microbiota in Kidney Donation and Transplantation

NCT05388955CompletedPrimary

Risk Assessment Tool for Graft Survival in Pediatric Kidney Transplantation

NCT05397821Unknown

Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques

Scroll to load more

Research Network

Activity Timeline